Adverse event | Omalizumab | Control |
Subjects n | 3678 | 2452 |
Any adverse event | 74.8 | 75.2 |
Upper respiratory tract infection | 15.7 | 15.7 |
Headache | 15.5 | 15.6 |
Nasopharyngitis | 14.4 | 15.9 |
Sinusitis | 10.1 | 12.0 |
Pharyngolaryngeal pain | 6.4 | 6.0 |
Cough | 5.9 | 7.1 |
Bronchitis | 5.2 | 5.6 |
Influenza | 5.0 | 6.6 |
Data are presented as %, unless otherwise stated. #: ≥5% in any group.